Answers are grounded in this paper and cite their sources.
The present study suggests that 1) the sampling strategy should be optimized according to pharmacokinetic profiles of the test drugs following oral microdosing, and 2) microdosing can be applied to the pharmacogenomic study of CYP-specific drugs.
No takes yet. Share an insight, caveat, or question.
Ieiri et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: